Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Harvard Medical School

- PMLiVE

AbbVie shares promising phase 3 results for Rinvoq in severe alopecia areata

Around 700,000 people in the US are living with some form of the autoimmune disease

- PMLiVE

FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata

Approximately 700,000 people in the US currently have some form of the autoimmune disease

- PMLiVE

FDA approves Sun Pharma’s oral JAK inhibitor Leqselvi to treat severe alopecia areata

The autoimmune disease currently affects around 700,000 people in the US

- PMLiVE

Researchers develop AI model to identify breast cancer stages and progression

Up to 50% of ductal carcinoma in situ patients progress to a highly invasive stage of cancer

- PMLiVE

MIT researchers develop new algorithmic framework to identify molecules for drug discovery

SPARROW balances time and cost when optimising molecular candidates to streamline

- PMLiVE

MIT protein study could help accelerate development of new antibiotics

Histidine kinase is a crucial bacterial protein that regulates processes, including antibiotic resistance

- PMLiVE

Researchers develop microneedle patch to reverse hair loss caused by alopecia areata

The autoimmune skin condition currently affects more than six million people in the US

- PMLiVE

New nanoparticle to deliver vaccines and generate strong immune responses at lower dose

MOF activates the innate immune system through TLRs to provoke strong immune responses

- PMLiVE

New drug interaction model could improve drug safety and effectiveness

The model found that the antibiotic doxycycline could interact with a common blood thinner, warfarin

- PMLiVE

Pfizer’s Litfulo recommended by NICE as first treatment for severe alopecia areata

Up to 14,000 patients living with the autoimmune disease could benefit from NICE’s decision

- PMLiVE

Medicxi forms Alys Pharma with six dermatology-focused companies with $100m

Alys will keep its component companies separate to focus on their platforms

- PMLiVE

Study finds doctors have difficulty diagnosing disease in images of darker skin

Researchers have found that AI could be used to more accurately diagnose these patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links